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ity of MCs to respond to proliferative stimuli by regulatingRequirement of heat shock protein 90 in mesangial cell mito-
critical mitogenic signaling steps necessary for G1 entry andgenesis.
S-phase progression.Background. Hyperplasia of mesangial cells (MCs) is a fre-
quent finding in glomerulonephritis. Heat shock protein 90
(HSP90) is a major cellular chaperone that assists protein fold-
ing under physiological and stress conditions.
Proliferation of resident glomerular cells in the normalMethods. To identify genes that are potentially involved in
kidney is tightly regulated with a growth rate of less thanthe pathogenesis of glomerulonephritis, we analyzed glomeru-
lar gene expression in mesangioproliferative rat anti-Thy1.1 1% [1]. However, many forms of glomerulonephritis, for
nephritis by representational difference analysis (RDA). Ex- example, IgA nephropathy, lupus nephritis, or postinfec-
pression of HSP90b in anti-Thy1.1 nephritis was studied by tious endocapillary proliferative glomerulonephritis, areNorthern and Western blot analyses and immunohistochemis-
characterized by mesangial hyperplasia caused by in-try. In cultured rat MCs, the requirement of HSP90 for mito-
genic signaling steps and MC replication was studied by incuba- creased replication of glomerular mesangial cells (MCs)
tion with the specific HSP90 inhibitor geldanamycin. [2]. While the induction of MC replication may reflect
Results. By RDA, a cDNA fragment homologous to HSP90b an early repair mechanism in the inflammatory response
was identified. Glomerular mRNA and protein expression of
to glomerular injury, persistent MC hyperplasia is patho-HSP90b was markedly and transiently up-regulated during the
genetically linked to progressive and irreversible glomer-course of anti-Thy1.1 nephritis, with a maximum at day 6,
coinciding with the peak of MC proliferation. By immunohisto- ular scarring. This concept is supported by several studies
chemistry, HSP90b expression in normal glomeruli was de- of experimental glomerular disease that demonstrated
tected in podocytes. However, in anti-Thy1.1 nephritis, glomer- that strategies to ameliorate MC mitogenesis can indeedular HSP90b protein expression was strongly and transiently
preserve glomerular function by preventing glomerulo-increased in mesangial localization. In vitro, mitogenic stimula-
sclerosis [3–5]. Numerous in vitro and in vivo studiestion of rat MCs led to the induction of HSP90b mRNA and
protein. Incubation of MCs with geldanamycin dose-depen- have identified regulatory mechanisms that are operative
dently inhibited DNA synthesis and replication. Moreover, in MCs and regulate proliferation. They involve multiple
geldanamycin interfered with mitogen-induced phosphoryla-
specific extracellular factors, for example, various solubletion of extracellular signal-regulated kinase and transcription
cytokines, autacoids, or hormones, and a complex arrayof c-fos and Egr-1, but not with transactivation of STAT1 tran-
scription factor. Cell cycle analysis of serum-stimulated MCs of receptor-mediated and nuclear signals that control
revealed that geldanamycin inhibited kinase activity of cyclin quiescence and cell cycle progression in MCs [6].
D1/CDK4 complexes and blocked progression in the G0/G1 Recently, the integral roles of heat shock proteinsphase and at the S/G2 phase transition.
(HSPs) in multistep processes leading to cell replicationConclusions. The up-regulation of HSP90b in anti-Thy1.1
have been recognized in various nonrenal cell types.nephritis may reflect its functional involvement in phenotypical
alterations of MCs in mesangioproliferative glomerulonephri- HSPs comprise several classes of ubiquitous, well-con-
tis. Our in vitro studies indicate that HSP90 governs the capac- served molecular chaperones involved in assisting cellu-
lar protein folding and preventing irreversible side-reac-
tions, such as unspecific aggregation of proteins [7]. AsKey words: cell cycle, proliferation of cells, glomerulonephritis, gelda-
namycin, hyperplasia, injury, renal scarring, protein folding. part of cellular defense mechanisms to prevent the dele-
terious consequences of protein unfolding, HSPs are rap-
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[7]. In addition to their function under stress conditions, 12, and 56 after induction of nephritis, and renal tissue
was obtained for immunohistochemistry, RNA extrac-HSPs also play a critical role under physiological condi-
tions by guiding the conformational maturation of a num- tion, and protein extraction. A group of four normal
animals served as a control.ber of regulatory proteins [8]. HSP90 is one of the most
abundant chaperones in eukaryotic cells and performs at
Representational difference analysisleast part of its function in an adenosine 59-triphosphate
(ATP)-dependent manner in complex with a set of part- The representational difference analysis (RDA) of
cDNA, as Hubank and Schatz described, was performedner proteins, including HSP70, HIP, HOP, p50, p23, and
large immunophilins [8]. Mammalian HSP90 is a homo- with the Clontech PCR-Select cDNA Subtraction Kit
(Clontech, Palo Alto, CA, USA) according to the manu-dimeric protein expressed as two isoforms, HSP90a and
HSP90b, that are encoded by separate genes located on facturer’s protocol [21]. For this purpose, total RNA was
extracted from isolated glomeruli from healthy controldifferent chromosomes [9]. GRP94 and TRAP1 consti-
tute the third and fourth closely related member of the rats and from rats five days after induction of anti-Thy1.1
nephritis as described previously [22]. The extraction ofHSP90 family [8]. HSP90 is an obligate component of
fundamental cellular processes such as hormone signal- glomerular mRNA from total RNA was achieved by use
of oligo-dT–coated polystyrene latex particles (Qiagen,ing and proliferation. In this context, several key regula-
tory proteins involved in mitogenic signaling pathways Hilden, Germany). The quality of mRNA preparations
was confirmed visually after electrophoresis in a 1% aga-or cell cycle control have been identified as substrates of
HSP90, including c-src, raf-1, Cdc37, and CDK4 [10–14]. rose gel.
Recently, HSP90 was shown to be the unique target for
Immunohistochemistrygeldanamycin, a potent new antitumor drug that blocks
cell proliferation [15, 16]. Geldanamycin is a fungal Methylcarnoy-fixed, paraffin-embedded 2 mm sections
were placed onto glass slides and incubated for 30 min-benzochinone ansamycin antibiotic that specifically in-
hibits HSP90. By crystallography, Stebbins et al demon- utes at 608C. Sections were then treated three times with
Xylol and rehydrated first in 100% ethanol and thenstrated that geldanamycin binds to a unique ATP-bind-
ing site in HSP90, thus interfering with the recruitment in 95% ethanol. Endogenous peroxidase activity was
blocked by incubating the sections for 20 minutes in 3%of its partner protein p23 [17]. Matsubara et al studied
protein localization of HSP90 in normal rat kidneys and hydrogen peroxide. The slides were washed in phosphate-
buffered saline (PBS) and blocked with fetal calf serumfound high HSP90 expression levels in epithelial cells in
distal tubules and collecting ducts [18]. In the glomerulus, (FCS). The sections were incubated with anti-HSP90,
clone 16F1, 1:500 (Stress Gen Biotechnology Corp., Vic-HSP90 was expressed to a lesser extent in glomerular
podocytes and Bowman epithelial cells [18]. While up- toria, Canada), anti-HSP90b, clone RB-118-P 1:100 (Neo-
Markers, Fremont, CA, USA), or anti-Thy1.1, cloneregulation of HSP90 expression was observed in proxi-
mal tubular epithelial cells in acute gentamicin nephrop- MRC OX-7, 1:100 (Serotec, Oxford, UK) at 48C over-
night. After rinsing three times in PBS for five minutes,athy [19], to our knowledge no reports exist to date about
its regulation in models of glomerular injury. the sections were incubated with the secondary antibody
labeled with biotin (Vector, Burlingame, CA, USA) forIn the present study, we investigated expression and
functional involvement of HSP90 in MCs in vitro and in 30 minutes at room temperature and were incubated
with peroxidase-conjugated avidin D for 30 minutes atvivo. Motivated by the identification of HSP90b as an
up-regulated gene in the rat mesangioproliferative anti- room temperature. After rinsing three times in PBS,
the peroxidase reaction was developed with the DABThy1.1 glomerulonephritis, we studied its localization
during the course of anti-Thy1.1 nephritis and explored Substrate Kit (Vector) for 10 minutes at room tempera-
ture. The sections were counterstained with hematoxylin,the functional role of HSP90 in mitogenesis of cultured
rat MCs. washed in water, dehydrated first in 95% ethanol and
then in 100% ethanol, and mounted with Entellan (Merck,
Darmstadt, Germany).
METHODS
Experimental disease Cell culture
Glomeruli from kidneys of male Sprague-Dawley ratsInbred male Sprague-Dawley rats (200 g) were ob-
tained from Charles River Deutschland (Sulzenfeld, (200 g) were isolated, and glomerular outgrowth and
subsequent subculturing of MCs were performed as de-Germany). Bagchus et al described the monoclonal anti-
body against Thy1.1 (ER4) [20]. Anti-Thy1.1 nephritis scribed previously [23]. MCs were maintained in Dulbec-
co’s modified Eagle’s medium (DMEM) supplementedwas induced by a single intravenous injection of 1 mg/kg
body weight of purified ER4 antibody into the tail vein. with 10% heat-inactivated (508C, 30 min) FCS, 50 U/mL
penicillin, 50 mg/mL streptomycin, 2 mmol/L glutamin,Groups of four animals were sacrificed on days 2, 5, 6,
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and 5 mg/mL insulin in a 95% air/5% CO2 humidified gel electrophoresis (SDS-PAGE) gel under reducing con-
atmosphere at 378C. MCs were used for experiments ditions. After electrophoresis, the gels were electroblot-
between passages 10 and 20. Before stimulation, MCs ted onto NC membranes (Amersham Life Science), and
were growth arrested by incubation for 72 hours in the transfer was controlled by Ponceau-S staining. Blots
DMEM supplemented with 0.4% heat-inactivated FCS, were incubated in PBS containing 0.5% Tween-20 and
50 U/mL penicillin, 50 mg/mL streptomycin, 2 mmol/L 3% bovine serum albumin (BSA) to block unspecific bind-
glutamin, and 5 mg/mL insulin (Sigma/Aldrich, Stein- ing, washed in PBS containing 0.5% Tween-20, and incu-
heim, Germany). bated with primary antibodies. Applied primary antibod-
ies were directed against HSP90b, 1:350 (clone RB-118-P;RNA extraction and Northern blot analysis
NeoMarkers); p42/p44 extracellular signal-regulated ki-
Mesangial cells were grown in 10 cm dishes until sub- nase (ERK), 1:1000 (Santa Cruz Biotechnology, Santa
confluency and were growth arrested for 72 hours in Cruz, CA, USA); phosphorylated p42/p44 ERK, 1:1000
medium containing 0.4% FCS. After mitogenic stimula- (New England Biolabs, Beverly, MA, USA); and CDK4,
tion with FCS or platelet-derived growth factor (PDGF) 1:2500 (Santa Cruz Biotechnology). Applied secondary
with or without addition of geldanamycin, cells were antibodies were peroxidase-conjugated goat antirabbit
washed twice in PBS and total RNA was extracted by
IgG, 1:10000 (Dianova, Hamburg, Germany). For visual-
the method of Chomczynski and Sacchi [24]. For the
ization, the enhanced chemiluminescence system (ECL;extraction of glomerular RNA, renal cortex was dis-
Amersham Life Science) was used according to the man-sected from kidneys from experimental animals and sac-
ufacturer’s protocol, followed by scanning densitomet-rificed at various time points after disease induction.
rical analysis.Glomeruli were isolated by the sieving technique as de-
scribed previously [23]. For RNA analysis, 15 mg of total Assessment of apoptosis
RNA were separated by electrophoresis in a 1% agarose-
Mesangial cells were seeded in 6 cm culture dishes andformaldehyde gel. The RNA was blotted from the gel
growth arrested by incubation with DMEM containingonto nylon membranes (Amersham LifeScience, Little
0.4% FCS for 72 hours. MCs were then stimulated withChalfont, UK) and baked at 808C for two hours. Mem-
10% FCS and treated with or without geldanamycin forbranes were prehybridized at 688C in ExpressHyb Hy-
48 hours. Cells were then scraped off the culture dishbridization Solution (Clontech). cDNA hybridization
and pelleted by centrifugation for two minutes at 1000 3 g.probes were labeled with a[32P]dCTP using a random
The cell pellet was resuspended in 50 mL paraformalde-primer labeling kit (Amersham Pharmacia Biotech, Lit-
tle Chalfont, UK). Hybridizations were at 688C in prehy- hyde (3% in PBS) and transferred onto a glass slide.
bridization solution containing radiolabeled cDNA probes After air drying, cells were stained with 100 mL Hoechst
at a concentration of 2 3 106 cpm/mL for one hour. Next, dye 33258 (8 mg/mL) for five minutes, washed three times
membranes were washed five times with 2 3 standard for five minutes in PBS, and covered with Tris-buffered
saline citrate (SSC)/0.1% sodium dodecyl sulfate (SDS). mowiol, pH 8.6 (Hoechst, Frankfurt, Germany). MC nu-
Blots were exposed to Kodak Biomax MS or MR films clei were visualized using a fluorescence microscope with
(Eastman Kodak Company, Rochester, NY, USA) at an excitation wave length of 340 to 380 nm and apoptotic
2808C for 16 hours, followed by scanning densitomet- MCs were determined by nuclear morphology.
rical analysis.
Determination of lactate dehydrogenase release
Protein extraction and Western blot analysis
Following incubations, medium of 3 3 105 MCs was
Subconfluent, quiescent MCs grown in 6 cm dishes
collected, and cells were lyzed by incubation with 0.2%
were harvested after stimulation with indicated soluble
(vol/vol) Triton-X 100 in PBS for 16 hours at 48C. Afactors at indicated time points in 200 mL RIPA solution
total of 500 mL of reaction mixture containing 50 mmol/L[50 mmol/L Tris-HCl, pH 7.2, 10 mmol/L ethylenediamine-
triethanolamine dissolved in 5 mmol/L EDTA, pH 7.6,tetraacetic acid (EDTA), pH 7.2, 150 mmol/L NaCl, 0.1%
127 mmol/L pyruvate, and 14 mmol/L nicotinamide ade-SDS, 1% sodium deoxycholate, 1% Triton X-100, 1
nine dinucleotide (NADH) in 1% NaHCO3 was addedmmol/L phenylmethylsulfonyl fluoride (PMSF), 2 mg/mL
to 300 mL of cell supernatant or lyzed cells. Lactateleupeptin, 100 mmol/L sodium orthovanadate]. Glomer-
dehydrogenase (LDH) activity was monitored by oxida-ular proteins were extracted using Tri-reagent (MRC
tion of NADH following the decrease in absorbance atInc., Cincinnati, OH, USA). Protein concentrations were
340 nm. The percentage of LDH release was defined asdetermined using the Bio-Rad DC Protein assay (Bio-
the ratio of LDH activity in the supernatant to the sumRad, Hercules, CA, USA). Protein samples containing 20
of the amount released plus the activity measured in themg total protein were denatured by boiling for five min-
utes and were separated on a 10% SDS-polyacrylamide cell lysate.
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Determination of 3H-thymidine uptake and of minutes at room temperature. For competition experi-
MC replication ments, a 100-fold excess of nonlabeled oligonucleotides
was used. For the supershift assay of STAT1 complexes,Five 3 103 MCs/well were seeded using 96-well plates
4 mg of antibody against STAT1 (Transduction Labora-in medium supplemented with 10% FCS until subconflu-
tories, Lexington, KY, USA) were added to the nuclearency. Cells were then growth arrested for 72 hours in me-
extracts before incubation with the labeled probe. Thedium supplemented with 0.4% FCS. Quiescent MCs were
samples were separated on a native 5% polyacrylamidetreated with geldanamycin, stimulated with PDGF-BB
gel. After electrophoresis, the gel was dried under vac-or with 5% FCS, and pulsed with 1 mCi/mL [3H-methyl]-
uum and exposed to Kodak x-ray film (Eastman Kodakthymidine (specific activity, 5 mCi/mmol; Amersham,
Company) for 16 hours.Braunschweig, Germany). Forty-eight hours after mito-
genic stimulation, MCs were washed twice with PBS,
Flow cytometric analysis of DNA contentlyzed with dH2O, and harvested onto filter paper using
Growth-arrested MCs were stimulated with 5% FCSan automated cell harvester (Bibby Dunn, Asbach, Ger-
in the absence or presence of 75 ng/mL geldanamycin.many). Incorporated counts were measured in a liquid
After 27 hours, MCs were washed twice with PBS, har-scintillation counter (Beckman, Mu¨nchen, Germany).
vested by trypsinization, washed twice with PBS, andTo assess cell numbers, 2 3 103 MCs/well were seeded
fixed in 70% ethanol in PBS for 30 minutes on ice.onto 96-well plates and growth arrested for 72 hours in
After two washes with PBS, MCs were incubated withmedium supplemented with 0.4% FCS. Mitogenic stimu-
RNAse A (2 mg/mL) for 30 minutes at 378C, washedlation of MCs was performed as for 3H-thymidine uptake.
twice with PBS, resuspended in 250 mL PBS, and stainedCell numbers were determined 48 hours after the addi-
with 50 mg/mL propidium iodide (Sigma/Aldrich). One 3tion of mitogens in the presence or absence of geldana-
106 MCs of each sample were analyzed with a Beckmanmycin. Monolayers were washed twice in PBS. MCs were
Coulter Epics XL cytometer and the System II softwaretrypsinized and transferred into 10 mL of Isoton (Coulter
(Beckman Coulter, Krefeld, Germany).Euro Diagnostics, Krefeld, Germany) for counting in a
Coulter counter (Coulter Electronics, Krefeld, Germany).
Kinase activity assay of cyclin D1/CDK4 complexes
Electrophoretic mobility shift assay Mesangial cells were lyzed in CDK4 immunoprecipita-
tion (IP) buffer (50 mmol/L HEPES, pH 7.5, 150 mmol/LNuclear extracts were prepared by using a modified
NaCl, 1 mmol/L EDTA, 2.5 mmol/L EGTA, 10% glyc-method described by Andrews and Faller [25]. MCs were
erol, 1 mmol/L DTT, 0.1% Tween-20, 10 mmol/L b-glycero-washed twice with ice-cold PBS and scraped from culture
phosphate, 1 mmol/L NaF, 0.1 mmol/L sodium orthovan-plates in 1 mL of PBS. After centrifugation, the cells were
adate, 2 mg/mL aprotinin, 5 mg/mL leupeptin, 1 mmol/Lresuspended in 400 mL buffer A [10 mmol/L HEPES, pH
PMSF). Cellular debris was removed by centrifugation7.9, 1.5 mmol/L MgCl2, 10 mmol/L KCl, 0.1 mmol/L EDTA,
at 48C for 10 minutes at 14,000 3 g. Five hundred micro-0.5 mmol/L dithiothreitol (DTT), 2 mmol/L Na3VO4, 0.5
grams of total protein were precleared with 30 mL Pro-mmol/L PMSF, 0.2 TIU/mL aprotinin] and kept on ice
tein A-Agarose (Santa Cruz Biotechnology) for twofor 15 minutes. Then 100 mL of 10% nonidet P40 was
hours at 48C. After centrifugation, cyclin D1/CDK4 com-added prior to vortexing. Cell lysates were centrifuged
plexes were immunoprecipitated by addition of 2 mg ofat 2000 3 g at 48C and were washed again with buffer A.
a mouse monoclonal antibody against cyclin D1 (Ab-2,Nuclear pellets were suspended in 50 mL buffer B (20
clone DCS-11; Neomarkers) for four hours at 48C fol-mmol/L HEPES, pH 7.9, 20% glycerol, 300 mmol/L KCl,
lowed by incubation with 30 mL Protein A-Agarose for0.2 mmol/L EDTA, 0.5 mmol/L DTT, 2 mmol/L Na3VO4,
16 hours at 48C. Precipitates were washed four times0.5 mmol/L PMSF, 0.2 TIU/mL aprotinin) and incubated
in IP buffer and twice in 50 mmol/L HEPES, pH 7.5,on ice for 30 minutes. The suspensions were centrifuged
containing 1 mmol/L DTT. Next, the precipitates wereat 14,000 3 g. The supernatants representing the nuclear
resuspended in kinase assay buffer (50 mmol/L HEPES,extracts were collected and stored at 2808C. For gel
pH 7.5, 10 mmol/L MgCl2, 1 mmol/L DTT, 2.5 mmol/Lmobility shift assays, 8 mg of nuclear extracts were incu-
EGTA, 10 mmol/L b-glycerophosphate) containing 1bated with 0.5 ng of g[32P]-ATP radiolabeled double-
mg/assay substrate protein GST-retinoblastoma tumorstranded oligonucleotides (Santa Cruz Biotechnology)
suppressor protein (Rb; Santa Cruz Biotechnology). ATPcontaining the signal tranducer and activator of tran-
was added to a final concentration of 50 mmol/L in addi-scription (STAT1) binding site (59-CATGTTATGCA
tion to 10 mCi of (g-32P) ATP (6000 Ci/mmol). The kinaseTATTCCTGTAAGT-39) [26] in 35 mL binding buffer
assay was performed at 308C for 30 minutes. Finally, the(10 mmol/L HEPES, pH 7.9, 10% glycerol, 70 mmol/L
samples were separated by SDS-PAGE and analyzed byKCl, 0.1 mmol/L EDTA, 0.5 mmol/L DTT, 6 mmol/L
MgCl2, 1.2 mmol/L CaCl2, 15 mg/mL poly dIdC) for 20 autoradiography.
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Materials
Geldanamycin was obtained from the NIH Drug Syn-
thesis and Chemistry Branch, Developmental Therapeu-
tics Program, Division of Cancer Treatment (National
Cancer Institute, Bethesda, MD, USA). Human recom-
binant HSP90b was a gift from Dr. D. Toft (Mayo Gradu-
ate School, Rochester, MN, USA). PDGF-BB was pur-
chased from Sigma/Aldrich and used in a concentration
of 25 ng/mL.
Statistical analysis
For statistical analysis, a two-way analysis of variance
(ANOVA), followed by post hoc Scheffe´ test, was used.
Values of P , 0.05 were considered significant. The
procedures were carried out using the SPSS software
(SPSS, Chicago, IL, USA). Values are displayed as
means 6 SD.
RESULTS
Glomerular mesangial cells up-regulate HSP90b
expression in anti-Thy1.1 nephritis
To identify genes potentially involved in the pathogen-
Fig. 1. (A) Northern blot analysis of HSP90b mRNA expression duringesis of mesangioproliferative glomerulonephritis, we em-
the course of rat anti-Thy1.1 nephritis. Each lane contains 15 mg of
ployed RDA [21], a polymerase chain reaction (PCR)- glomerular RNA isolated from healthy control animals or from nephritic
animals (N 5 4) at indicated time points after induction of the disease.based subtractive hybridization method. For this purpose,
(Lower panel) 18S RNA loading control stained with ethidium bromide.mRNAs were extracted from isolated glomeruli of nor-
(B) Western blot analysis of HSP90b protein expression during the
mal control animals and of rats five days after induction course of rat anti-Thy1.1 nephritis. Each lane contains 30 mg of glomeru-
lar protein lysates isolated from healthy control animals or from ne-of anti-Thy1.1 nephritis. By comparison of glomerular
phritic animals (N 5 4) at the indicated time points after induction ofgene expression patterns, we identified a 248 bp fragment the disease. Positive control: 0.5 mg of recombinant HSP90b (rHSP90b).
homologous to rat HSP90b (bases 1843 to 2091; Gen-
Bank accession number S45392) in the cDNA pool rep-
resenting genes with increased expression in nephritic
cifically reacted with recombinant HSP90b protein byglomeruli.
Western blot analysis and exhibited identical stainingTo independently confirm this result obtained by
patterns in normal kidneys and in nephritic kidneys. InRDA, we investigated glomerular expression levels of
normal kidneys from healthy control animals, a basalHSP90b mRNA and protein during the course of mesan-
HSP90b expression was observed in distal tubules andgioproliferative anti-Thy1.1 nephritis induced by injec-
collecting ducts (data not shown) as well as in glomerulartion of monoclonal ER4 antibody. Northern blot analysis
podocytes. During the course of anti-Thy1.1 nephritis,of RNA extracted from isolated glomeruli revealed a
HSP90b expression was strongly and transiently up-marked and transient increase of HSP90b expression
regulated in glomeruli with a maximum at day 6 afterduring the course of anti-Thy1.1 nephritis, peaking at
induction of the disease (Fig. 2A). Control sections incu-day 6 of the disease with a 7.6-fold increase of HSP90b
bated in the absence of primary antibody were negativemRNA, as analyzed by scanning densitometry (Fig. 1A).
(Fig. 2A). Moreover, staining of sequential sections forMoreover, Western blot analysis of protein lysates from
HSP90b and the MC marker Thy1.1 on day 6 of anti-isolated glomeruli showed a strong induction of HSP90b
Thy1.1 nephritis identified most HSP90b-expressing cellsprotein during the course of the disease, with a maximal
as MCs (Fig. 2B).12.7-fold increase at day 12 after induction of anti-Thy1.1
nephritis (Fig. 1B).
Mitogenic stimulation of cultured MCs inducesTo localize HSP90b expression in normal and nephritic
HSP90b mRNA and protein expressionrat kidneys, immunohistochemistry was performed on
methylcarnoy-fixed, paraffin-embedded sections. Two dif- The observation that HSP90b was up-regulated in
MCs during the course of mesangioproliferative anti-ferent HSP90 antibodies, clones 16F1 and RB-118-P, spe-
Fig. 2. (A) Immunohistochemical localization
of glomerular HSP90b protein expression dur-
ing the course of rat anti-Thy1.1 nephritis. Tis-
sue sections were obtained from rat kidneys
of healthy control animals (co) or of nephritic
animals at days (d) 2, 6, 12, and 56 after disease
induction. HSP90b-positive immunoreactivity
is indicated by the brown staining pattern (mag-
nification 3400). (B) Immunohistochemical co-
localization of HSP90b- and Thy1.1-expressing
cells in sequential sections of kidney tissue from
nephritic animal six days after induction of anti-
Thy1.1 nephritis. HSP90b-positive immunore-
activity is indicated by brown staining. Thy1.1-
positive immunoreactivity shows black staining
(magnification 3400).
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Geldanamycin dose-dependently inhibits MC
proliferation in vitro
To analyze the functional role of HSP90 in MC mito-
genesis, we incubated MCs with the specific HSP90 inhib-
itor geldanamycin. To assess possible toxic effects of
geldanamycin on MCs, LDH release and apoptotic cell
numbers were determined. In the absence or presence
of 5% FCS, incubation of MCs with 75 ng/mL geldana-
mycin for 48 hours did not significantly increase LDH
release, as compared with untreated control MCs or MCs
incubated with the vehicle dimethyl sulfoxide (DMSO)
alone (data not shown). Apoptotic MCs were determined
by nuclear morphology after staining with Hoechst dye
33258. Incubation of MCs with 75 ng/mL geldanamycin
for 48 hours did not increase apoptotic cell numbers as
compared with DMSO-treated control MCs. Percent-
ages of apoptotic MCs were less than 2% in geldana-
mycin-treated MCs and in control MCs.
To investigate how interference with HSP90 function
affects MC proliferation, we examined the effects of
geldanamycin on FCS-stimulated 3H-thymidine uptake
Fig. 3. (A) Northern blot analysis of HSP90b mRNA expression in and cell replication. Incubation of MCs with geldana-
cultured rat mesangial cells (MCs) growth-stimulated with serum. Fif- mycin for 24 hours dose-dependently and significantly
teen micrograms of total RNA per lane from quiescent MCs or from
blocked 3H-thymidine uptake (Fig. 4A). Moreover, repli-MCs incubated with 5% FCS harvested at the indicated time points
were examined. (Lower panel) 18S RNA loading and transfer control cation of serum-stimulated MCs was also dose-depen-
by membrane staining with methylene-blue. The shown data are from dently and significantly inhibited by geldanamycin, asone representative out of three experiments. (B) Western blot analysis
determined by MC numbers (Fig. 4B). To exclude anti-of HSP90b protein expression in cultured rat MCs after growth stimula-
tion of quiescent MCs with 5% FCS or 25 ng/mL PDGF. MCs were adhesive effects of geldanamycin, MC counts were also
harvested 12 and 24 hours after addition of mitogenic factors. Control: determined in the supernatants, which were #60 MCs inquiescent MCs. rHSP90b: 0.5 mg of recombinant HSP90b (antibody
the presence or absence of geldanamycin. DNA synthesiscontrol). The data depicted are from one representative out of three
experiments. and replication of MCs were not affected by incubation
with the vehicle DMSO alone (Fig. 4). In addition, incu-
bation of MCs with geldanamycin also inhibited the
PDGF-driven MC replication in a dose-dependent man-
Thy1.1 nephritis formed the basis for our working hy- ner (data not shown).
pothesis, which proposed that HSP90b mediates crucial
mitogenic signaling steps in MCs. To elucidate further Geldanamycin interferes with mitogen-induced
the role of HSP90b in the proliferative response of MCs, activation of the ERK pathway but not with
we studied its regulation and function in cultured rat transactivation of STAT1 transcription factor
MCs. Mitogenic stimulation of growth-arrested MCs To elucidate further the functional involvement of
with 5% FCS was associated with a rapid induction of HSP90 in proliferation-related signaling pathways of
HSP90b mRNA expression, as assessed by Northern MCs, we examined how geldanamycin affects major mi-
blot analysis (Fig. 3A). Compared with quiescent control togenic signaling steps in MCs, that is, phosphorylation
MCs, HSP90b mRNA levels were clearly up-regulated of ERK1 and ERK2, transcriptional activation of imme-
as early as 1.5 hours after stimulation with FCS and were diate early genes (IEGs), and transactivation of STAT1
maximally increased 9.0-fold after 12 hours, as analyzed transcription factor. Mitogenic stimulation of quiescent
by scanning densitometry. In addition, by Western blot MCs with 5% FCS led to a sustained increase of phos-
analysis, we found maximally enhanced HSP90b protein phorylation of ERK2 (p42) and predominantly of ERK1
expression 24 hours after mitogenic stimulation with 5% (p44), which was detectable from 10 to 120 minutes after
FCS, reflecting a 6.6-fold increase of HSP90b protein, as addition of serum (Fig. 5, upper panel). However, the
assessed by densitometric analysis (Fig. 3B). A moderate presence of 75 ng/mL geldanamycin clearly reduced phos-
2.4-fold induction of HSP90b protein expression was also phorylation of ERK1 and ERK2 30, 60, and 120 minutes
found after incubation with 25 ng/mL PDGF for 12 hours after stimulation of serum. The geldanamycin-induced
reduction of ERK phosphorylation was not due to lower(Fig. 3B).
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was markedly reduced in the presence of 75 ng/mL gelda-
namycin (data not shown). Since the serum-response
element (SRE)-related induction of IEGs is a major sig-
naling event downstream of ERK activation, we exam-
ined how geldanamycin affects the transcriptional activa-
tion of the IEGs c-fos and Egr-1 by Northern blot
analysis. Incubation of MCs with geldanamycin in con-
centrations up to 75 ng/mL dose-dependently reduced
the expression of c-fos and Egr-1 in PDGF- and FCS-
stimulated MCs (Fig. 6).
Platelet-derived growth factor-induced activation of
DNA-binding of STAT1 [27, 28] was examined by elec-
trophoretic mobility shift assay (EMSA) using double-
stranded oligonucleotides containing the STAT1 binding
motif [26]. As demonstrated in Figure 7, the addition of
25 ng/mL PDGF led to the rapid formation of STAT1/
DNA complexes. The specificity of these complexes was
verified by efficient competition of the signal by excess
of unlabeled oligonucleotides and by supershift of the
signal by incubation with an antibody directed against
STAT1 (Fig. 7). However, this complex formation was
not affected by coincubation with 75 ng/mL geldana-
mycin, indicating that geldanamycin does not interfere
with the activation, nuclear translocation, or DNA bind-
ing capacity of STAT1 transcription factor in MCs.
Geldanamycin blocks cell cycle progression in the
G 0 /G1 phase and at the S/G2 phase transition of
serum-stimulated MCs
Analysis of cell cycle distribution of quiescent MCs
stimulated with 5% FCS for 27 hours revealed that co-
incubation with 75 ng/mL geldanamycin increased the
percentage of MCs remaining in G0/G1 phase, as com-
pared to MCs incubated with 5% FCS alone (66.3 vs.
44.8%), reflecting a failure to exit G0 and to enter G1
and/or cell cycle arrest in G1 phase (Fig. 8). Since coincu-Fig. 4. (A) 3H-thymidine uptake assay. Quiescent cultured rat MCs
were stimulated with 5% FCS in the presence of indicated concentra- bation of serum-stimulated MCs with geldanamycin also
tions of geldanamycin; DMSO is the vehicle control. 3H-thymidine
markedly decreased the percentage of MCs residing inuptake was determined 48 hours after stimulation. Values given are
the G2/M phase, we further examined the possibility thatmeans 6 SD of five samples. The shown data are from one representa-
tive out of three experiments. (B) Determination of MC numbers. geldanamycin arrests MCs in the S phase. For this pur-
Quiescent cultured rat MCs were stimulated with 5% FCS for 48 hours
pose, quiescent MCs were stimulated with 5% FCS andin the presence of indicated concentrations of geldanamycin; DMSO
were allowed to transit through the G1 phase for eightis the vehicle control. Values given are means 6 SD of three samples.
The shown data are from one representative out of two experiments. hours before addition of 75 ng/mL geldanamycin. This
Significances were calculated comparing MCs incubated with 5% FCS
experimental procedure leads to an accumulation of MCsand geldanamycin to MCs stimulated with 5% FCS and treated with
in the S phase (44.0%), consistent with an inhibition ofDMSO (*P , 0.05).
the S/G2 transition.
Geldanamycin inhibits kinase activity of cyclin
D1/CDK4 complexesprotein loads, as shown by Western blot analysis of total
p42/p44 (Fig. 5, lower panel). In addition, we examined Mitogenic stimulation of quiescent MCs with 15%
the effects of geldanamycin on PDGF-stimulated phos- FCS for four hours led to a marked increase of cyclin
phorylation of ERK1 and ERK2. Incubation of growth- D1/CDK4 kinase activity, as demonstrated by GST-Rb-
arrested MCs with 25 ng/mL PDGF rapidly induced kinase assay (Fig. 9). However, preincubation of quies-
phosphorylation of p42/p44. Similar to the effects ob- cent MCs with 75 ng/mL geldanamycin for 16 hours as
well as coincubation with 75 ng/mL geldanamycin clearlyserved in serum-stimulated MCs, this phosphorylation
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Fig. 5. Western blot analysis of ERK1 and
ERK2 (p42/p44) phosphorylation. Quiescent
cultured rat MCs were stimulated with 5%
FCS in the presence or absence of 75 ng/mL
geldanamycin (GA). MCs were harvested 10,
30, 60, or 120 minutes after the addition of
FCS. Twenty micrograms of protein per lane
were size fractionated by SDS-PAGE, and
abundances of phosphorylated p42/p44 (up-
per panel) and of total p42/p44 protein (lower
panel) were determined by Western blot anal-
ysis. The shown data are from one representa-
tive out of three experiments.
Fig. 6. Northern blot analysis of c-fos and Egr-1 mRNA expression in cultured rat MCs. Growth-arrested rat MCs were stimulated with 25 ng/mL
PDGF or 5% FCS in the presence or absence of indicated concentrations of geldanamycin (GA); DMSO is the vehicle control. MCs were harvested
30 minutes after mitogenic stimulation. Fifteen micrograms of total RNA per lane were size fractionated by gel electrophoresis, and mRNA
expression levels of c-fos and Egr-1 were examined by Northern blot analysis. (Lower panel) 18S RNA loading and transfer control by membrane
staining with methylene-blue. The shown data are from one representative out of two experiments.
inhibited the FCS-induced increase of cyclin D1/CDK4 study, we employed this model to identify genes involved
in the pathogenesis of mesangioproliferative glomerulo-kinase activity.
nephritis by RDA [21]. RDA is a PCR-coupled sub-
tractive hybridization technique allowing discovery of
DISCUSSION differentially regulated genes in two cDNA pools and
A central feature of many types of glomerulonephritis has previously been successfully applied, for example,
is glomerular hypercellularity caused by MC hyperplasia. to study gene expression in the 5/6 nephrectomy model
The concept has been advanced that ongoing MC repli- of the mouse [30]. By comparison of gene expression
cation also activates the synthetic secretory phenotype from mRNAs extracted from normal glomeruli and ne-
of MCs and is associated with the development of glo- phritic glomeruli isolated five days after induction of
merulosclerosis and progressive loss of renal function anti-Thy1.1 nephritis, we were able to identify differen-
[2]. The anti-Thy1.1 model of mesangial proliferative tial expression of HSP90b. HSP90 is a chaperone that
glomerulonephritis is characterized by intense MC pro- regulates protein folding under physiological and stress
liferation [20] and has been used to investigate the in conditions. Its substrates include steroid receptors, src,
raf, and cell cycle-regulatory proteins [8]. To confirm thevivo relevance of MC hyperplasia [3–5, 29]. In the present
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By immunohistochemistry, we detected HSP90b ex-
pression in normal kidneys in podocytes and epithelial
cells of distal tubules and collecting ducts, consistent with
observations by Matsubara et al [18]. However, during
the course of anti-Thy1.1 nephritis, glomerular HSP90b
protein expression was strongly and transiently increased
in mesangial localization with a maximum six days after
induction of the disease. Since activated macrophages
represent the predominant infiltrating inflammatory cells
in anti-Thy1.1 nephritis, it is possible that HSP90-posi-
tive macrophages contribute to the mesangial staining
pattern in vivo. However, by immunohistochemistry with
the macrophage/monocyte-specific marker ED-1, we found
2.25 6 1.62 positive cells per glomerular cross-section
in nephritic animals from day 6 of the disease (control
animals, 0.37 6 0.62 ED-1–positive cells). Thus, the po-
tential contribution of macrophages to the maximum of
glomerular HSP90 staining at day 6 appears relatively
minor. While this is the first report on the regulation
of HSP90b in experimental glomerulonephritis, several
studies have investigated expression of HSP90 in models
of tubular injury. Immunohistochemical studies demon-
strated up-regulation of HSP90 protein expression in
injured or regenerative tubular epithelial cells in acute
gentamicin nephropathy, cisplatin-induced acute renal
failure, and unilateral renal ischemia [19, 31, 32].
The observation that HSP90b expression correlated
spatially and temporally with MC replication in anti-
Thy1.1 nephritis led us to investigate how HSP90b ex-
pression is regulated by mitogenic stimuli in cultured
MCs and whether HSP90 action is required for prolifera-
tion of MCs in vitro. Indeed, mitogenic stimulation of
cultured rat MCs with FCS or PDGF was associated with
Fig. 7. Electrophoretic mobility shift assay (EMSA) of MC nuclear an increase of HSP90b mRNA and protein. FCS induced
protein extracts incubated with double-stranded oligonucleotides con- HSP90b protein expression more potently than PDGF,
taining the binding site for STAT1. Quiescent rat MCs were stimulated
which could reflect the involvement of different signalwith 25 ng/mL PDGF in the presence or absence of 75 ng/mL geldana-
mycin (GA). MCs were harvested 20 minutes after mitogenic stimula- transduction pathways regulating HSP90b expression in
tion, and 8 mg of nuclear extracts were incubated with radioactively MCs. Classic inductors of HSP90b expression include
labeled STAT1 oligonucleotides. The dark arrow indicates the position
stress stimuli, such as elevated temperature, metal ions,of DNA-protein complex formed after stimulation with PDGF. Speci-
ficity control, lane 3: addition of 100-fold excess of competitive, unla- or amino acid analogues [7]. In addition, interleukin-6
beled STAT1-oligonucleotides. The open arrow indicates the position and interferon-g have recently been shown to induce
of “supershifted” STAT1/DNA complexes in lane 4 after incubation
HSP90b expression in hepatoma cells via transactivationwith an antibody directed against STAT1. Lane 6: labeled STAT1-
oligonucleotides without addition of nuclear extracts. The shown data of STAT3 and STAT1, respectively [33, 34]. Conceiv-
are from one representative out of three experiments. ably, inflammatory cytokines and mitogenic peptides
may contribute to the induction of MC HSP90b expres-
sion in anti-Thy1.1 nephritis.
To test whether HSP90 is functionally required forresult obtained via RDA by independent methods, North-
MC mitogenesis, we incubated MCs with the ansamy-ern blot and Western blot analyses from glomerular
cin antibiotic geldanamycin, which specifically inhibitsRNA and protein lysates were performed and revealed
HSP90 by binding to its ATP binding site [17]. Becausepronounced and transient up-regulation of HSP90b
of this mechanism, geldanamycin blocks both HSP90amRNA and protein expression during the course of anti-
and HSP90b isoforms and does not allow distinguish-Thy1.1 nephritis. The maximum of HSP90b mRNA and
ing functionally between these two major mammalianprotein expression was found at day 6 of anti-Thy1.1
HSP90 isoforms. In the rat, expression studies of HSP90anephritis, coinciding with the peak of MC proliferation
in this model [20]. in cells and tissues are not feasible since the rat HSP90a
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Fig. 8. Cell cycle analysis of MCs by FACS
analysis of DNA content after propidium io-
dide staining. (A) Quiescent MCs grown for 72
hours in 0.4% FCS. (B) MCs were stimulated
with 5% FCS. (C) MCs were stimulated with
5% FCS and coincubated with 75 ng/mL gel-
danamycin. (D) MCs were stimulated with 5%
FCS, and 75 ng/mL of geldanamycin were added
eight hours after addition of FCS. (B–D) MCs
were harvested 27 hours after stimulation with
5% FCS. The shown data are from one repre-
sentative out of two experiments.
geldanamycin in fibroblasts [11] and a number of tumor
cell lines [16].
To elucidate further the functional involvement of
HSP90 in mitogenic signaling pathways of MCs, we ex-
amined how geldanamycin affects major signaling steps
in MCs, that is, phosphorylation of ERK1 and ERK2,
transcriptional activation of IEGs, and transactivation of
STAT1 transcription factor. In PDGF-stimulated MCs,
geldanamycin caused a reduction of ERK phosphoryla-
tion. While ERK has not been shown to be a direct
substrate of HSP90, the serine/threonine kinase Raf-1
Fig. 9. Geldanamycin inhibits cyclin D1-associated CDK4 kinase activ- signaling upstream of ERK was found to be stabilized
ity in rat MCs. Quiescent MCs grown in 0.4% FCS were preincubated by HSP90 [11]. Raf-1 exists in a complex with HSP90
(GA 16 hours pre) or coincubated (GA co) with 75 ng/mL geldanamycin
and functions downstream of Ras in a signal transductionand stimulated with 15% FCS. Four hours after mitogenic stimulation,
whole cell lysates were extracted and immunoprecipitated with an cascade, which transmits mitogenic stimuli from the
anticyclin D1 antibody (IP-control). Cyclin D1/CDK4 kinase activity plasma membrane to the nucleus [11]. Raf-1 integrates
was assessed by GST-Rb kinase assay (upper panel). As negative con-
signals from extracellular factors and, in turn, activates itstrol, no IP antibody was added to lysates of MCs stimulated with 15%
FCS (lane 5). Phosphorylated GST-Rb substrate protein was analyzed substrate, MEK kinase (mitogen-activated protein kinase
by autoradiography (upper panel), and coimmunoprecipitated CDK4 kinase). MEK activates ERK, which phosphorylates otherprotein was visualized by Western blot analysis (lower panel). The
kinases as well as transcription factors. In tumor cells andshown data are from one representative out of three experiments.
fibroblasts, geldanamycin disrupted the Raf-1-HSP90
complex and was sufficient to block Raf-1-MEK-ERK
signaling and cell proliferation [11, 35]. In addition to
sequence has not been cloned to date and specific rat the inhibition of ERK phosphorylation in MCs, we found
HSP90a antibodies are not yet available. Incubation of that geldanamycin reduced the FCS- and PDGF-stimu-
mitogen-stimulated MCs with geldanamycin effectively lated transcription of c-fos and Egr-1, two IEGs activated
and dose-dependently inhibited DNA synthesis and cell by ERK via serum-response elements in MCs [36–38].
replication. The growth-inhibitory effect of geldana- It is conceivable that geldanamycin-induced destabiliza-
mycin in MCs was not due to toxic effects or induction tion of Raf-1 leading to inhibition of ERK is also a
of apoptosis, as assessed by LDH release and nuclear mechanism operative in MCs, which consequently con-
morphology. These findings demonstrate the functional tributes to the inhibition of IEG expression.
requirement of HSP90 for MC proliferation and are in A number of mitogenic peptide growth factors, for
example, PDGF, can act through phosphorylation andkeeping with observations of antimitogenic effects of
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nuclear translocation of STAT1 transcription factor [41, 42]. Conceivably, strategies aiming at interfering
[27, 28]. Phosphorylated STAT1 is capable of activating with HSP90’s function in vivo may lead to new ap-
sis-inducible elements (SIE) located in the promoter re- proaches of inhibiting MC replication in mesangioproli-
gion of target genes, which mediate proliferative signals, ferative glomerulonephritis.
including c-fos [36]. We tested the functional involve-
ment of HSP90 for PDGF-induced transactivation of ACKNOWLEDGMENTS
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